Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 539 of 5804
-
Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
Prevention OngoingThe goal of this pilot clinical trial is to learn if an intervention that trains Gancheros (people who provide injection services in exchange for drugs or money) to conduct risk-reduction outreach could help lower risk for human immunodeficiency virus (HIV), hepatitis C virus (HC…
Phase: NA • Sponsor: North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI) • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
New hope for hard-to-treat leukemia: drug combo enters phase 2 trial
Disease control Recruiting nowA treatment cycle is 28 days. Tagraxofusp will be administered at 9 mcg/kg IV over 15 minutes (-5 or +15 minutes) daily for 3 consecutive days (or 3 doses over a period not to exceed 10 days if postponement is required to allow for toxicity resolution), followed by azacitidine ad…
Phase: PHASE2 • Sponsor: Joshua Zeidner • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New trial aims to tailor breast cancer treatment using PET scans
Disease control Recruiting nowEligible patients with stage 2 and 3 triple negative breast cancer will be treated with 4 cycles of neoadjuvant paclitaxel/carboplatin/pembrolizumab. A PET scan will be performed at baseline and after 1 cycle of therapy. A breast MRI will be performed after treatment completion. …
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a common cholesterol drug stop chronic migraine?
Disease control Recruiting nowThe main objective of this study is to see whether the favorable preventative effect of Atorvastatin 40mg per day in episodic migraine, that was found previously in three smaller randomized controlled cross-over studies, can be confirmed in a larger, multicenter, randomized contr…
Phase: PHASE2 • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Brain training for tiny hearts: can a Game-Like program sharpen young minds after heart surgery?
Disease control OngoingAdvances in prenatal and neonatal care have improved outcomes in children with severe congenital heart disease (CHD). With the increase in survival, neurocognitive problems such as executive functioning (EF) impairments have become more apparent in these children. EF problems hav…
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New combo therapy aims to wipe out colon cancer before surgery
Disease control Recruiting nowThe goal of this clinical trial is to learn the effect of neoadjuvant chemotherapy plus sequential immune checkpoint inhibitor (ICI) therapy in locally advanced colon cancer. The main questions it aims to answer are: * Does this neoadjuvant chemotherapy increase the pathologic c…
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Cheap antioxidant could replace costly drugs for Post-Transplant blood disorder
Disease control OngoingThis multicenter, prospective, single-arm clinical trial aims to evaluate the efficacy and safety of N-acetylcysteine (NAC) for treating Transplantation-Associated Thrombotic Microangiopathy (TA-TMA), a severe complication of hematopoietic stem cell transplantation characterized …
Phase: PHASE2, PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for bile duct cancer: targeted combo targets hard-to-treat gene mutation
Disease control Recruiting nowThis is a multicenter, non-randomized, umbrella, open-label phase II clinical study, aiming to observe and evaluate, as well as explore the efficacy and safety of precision targeted therapy based on NGS technology for IDH1-mutated patients, specifically the combination of ivoside…
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New gel could heal diabetic foot ulcers faster
Disease control Recruiting nowThis is a randomized, double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic lower leg and foot ulcer.
Phase: PHASE2 • Sponsor: Blue Blood Biotech Corp. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental cocktail targets deadly brain lymphoma
Disease control Recruiting nowSecondary involvement of the central nervous system (CNS), such as CNS relapse after treatment or progression during treatment, is a rare but deadly occurrence in patients with B-cell non-Hodgkin lymphoma (NHL), particularly in cases of diffuse large B-cell lymphoma (DLBCL) and t…
Phase: PHASE1, PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New eye drug could save sight for millions with diabetes
Disease control CompletedThis study will demonstrate that tarcocimab 5 mg is superior to sham treatment in participants with DR.
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New study: Protein-Rich diet and exercise before surgery may help older cancer patients recover faster
Symptom relief Recruiting nowIn this pragmatic clinical trial, the investigators will study older Veterans approaching surgery for gastrointestinal or genitourinary cancer who are at high risk for a marked decline in their physical function. The investigators will test a multi-targeted nutrition regimen high…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New cocktail aims to make liver cancer operable
Disease control TerminatedPrimary liver cancer mainly consists of three different pathologic types: hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and hybrid HCC-ICC, of which HCC accounts for 90%. According to GLOBOCAN 2018 data, liver cancer is the sixth most prevalent tumor in the world, wi…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Virus and pill combo takes on recurrent brain tumors
Disease control Recruiting nowThe purpose of this study is to determine if the investigational products, DB107-RRV and DB107-FC, as a combination treatment will shrink high-grade glioma (HGG) in patients with recurrent/progressive, resectable or unresectable disease and increase the time that disease is contr…
Phase: PHASE2 • Sponsor: Ashish Shah • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a probiotic ease autism symptoms? new trial investigates
Disease control Recruiting nowWith an increased prevalence of autism spectrum disorder (ASD) worldwide and in Taiwan, ASD demands urgent attention due to its lasting impact, unclear causes, and limited diagnostic and treatment options. Recent studies highlight disruptions in the gut-brain axis, particularly i…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Microwave zaps prostate cancer while preserving normal function
Disease control OngoingThis clinical trial is to provide a minimally invasive treatment option in which the targeted prostate cancer tissue is killed by microwave only in the specific area of cancer "that should be treated for saving of life," while leaving a portion of the normal prostate tissue that …
Phase: NA • Sponsor: Osamu Ukimura • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Robot-Assisted bronchoscopy may diagnose and treat lung nodules in one go
Disease control CompletedTo evaluate the safety and feasibility of a single-session "diagnose and treat" (one-stop) paradigm utilizing robotic-assisted bronchoscopy (RAB).
Phase: NA • Sponsor: Jisong Zhang • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug aims to stop swelling attacks in hereditary angioedema
Disease control Recruiting nowProspective, multicenter, randomized, double-blind, parallel group, placebo- controlled, efficacy and safety phase 3 study of an intravenous human plasma- derived C1 esterase inhibitor (C1-INH) concentrate in participants with congenital C1-INH deficiency for the treatment and pr…
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Engineered immune cells take on deadly brain tumors in first human trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of E-SYNC chimeric antigen receptor (CAR) T cells after lymphodepleting chemotherapy in treating patients with EGFRvIII positive (+) glioblastoma. Chimeric antigen receptor (CAR) T-cell therapy is a type of treatmen…
Phase: PHASE1 • Sponsor: Hideho Okada, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can weight loss drugs boost heart function in obese heart failure patients?
Disease control Recruiting nowThe benefit of weight loss in patients with obesity and heart failure with reduced ejection fraction (HFrEF) is controversial. Semaglutide has shown cardiovascular (CV) risk-reduction and impact on CV risk factors including overweight, dysglycaemia and hypertension in subjects wi…
Phase: PHASE2, PHASE3 • Sponsor: Jens D Hove, MD,PHD • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC